Skip to content

Joining forces to develop and evaluate a toolkit to promote sustained lifestyle change among overweight and obese multimorbid individuals with a combination of the chronic diseases type 2 diabetes mellitus, cardiovascular disease, and/or cancer: the Lifestyle medicine for individuals with multiple chronic diseases (LifeMeds) study

Joining forces to develop and evaluate a toolkit to promote sustained lifestyle change among overweight and obese multimorbid individuals with a combination of the chronic diseases type 2 diabetes mellitus, cardiovascular disease, and/or cancer: the Lifestyle medicine for individuals with multiple chronic diseases (LifeMeds) study - LifeMeds

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON56754
Enrollment
100
Registered
2024-03-18
Start date
2025-01-24
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

comorbidity multimorbidity multiple chronic diseases

Interventions

None listed

Sponsors

Universiteit van Tilburg
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - A combination of cancer, CVD and/or T2DM. - Aged 18 years or older

Exclusion criteria

Exclusion criteria: - A life expectancy of less than 1 year - Not fluent enough in spoken Dutch or English language at a sufficient level to be able to complete questionnaires. - Refusal to IC. - With significant cognitive impairment (e.g. major neurocognitive disorder) - Diagnosed with a psychiatric disorder

Design outcomes

Primary

MeasureTime frame
In-depth information on the most important perceived barriers and facilitators of sustained lifestyle (change) (obtained from the interviews and focus groups) and insight into the real-time interrelation and relative importance of observed barriers and facilitators of lifestyle (change) and how these are influenced by contextual factors (e.g. social and physical environment). Eventually, the study endpoint is a co-created toolkit and training program for the promotion of (sustained) lifestyle changes. These will undergo feasibility and pre-efficacy testing, ultimately resulting in a plan for its adoption, implementation, and evaluation.

Countries

Netherlands

Contacts

Public ContactM Hoedjes

Universiteit van Tilburg

m.hoedjes@tilburguniversity.edu-

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)